Alabama Took Five Years to Open Its First Cannabis Dispensary. It’s Finally Happening.
Alabama medical cannabis access has expanded with the opening of the state's first dispensary. This milestone offers new treatment options for qualifying patients. It marks a significant change in Alabama's restrictive cannabis policies.
CED Digest: 30 Items — March 31, 2026
This CED Digest highlights cannabis compounds CBD and CBG therapeutic effects on fatty liver disease and metabolic health. Clinicians can consider these compounds for evidence-based patient management. The digest provides 30 clinically relevant items for…
Audit Finds Alabama Medical Cannabis Commission Violated State Law in Five Areas
An audit identified Alabama Medical Cannabis Commission violations affecting regulatory compliance and patient access. These violations raise concerns about quality control and program implementation. Ensuring adherence to state law is critical for…
Audit Uncovers Violations in Alabama Medical Cannabis Commission
The Alabama Medical Cannabis Commission audit highlights significant financial violations and oversight concerns. These findings raise questions about regulatory effectiveness in Alabama's medical cannabis program. Patients and clinicians should monitor…
CED Digest: 239 Items — March 17, 2026
CED DigestMarch 17, 2026. 239 items curated for clinical relevance. Above Threshold Alabama Medical Cannabis Sales Gear for Spring 2026 LaunchAlabama's medical cannabis program expects to begin patient sales in spring 2026, requiring clinicians to…
CED Digest: 392 Items — March 11, 2026
The CED Digest for March 11, 2026, highlights cannabis compounds CBD and CBG with potential therapeutic effects. These cannabinoids may help reduce fatty liver disease and improve metabolic health. Clinicians can consider this evidence when advising…